APIs para pesquisa e impurezas

PSI 352707 Ammonium Salt is a drug product that has been custom synthesized and is high purity with CAS No. 1233335-78-8. It has analytical and metagenomic studies, as well as pharmacopoeia and metabolite standards. This drug product is used for drug development and research & development purposes as an impurity standard for HPLC.

15-Epi travoprost is a synthetic, natural, and impurity standard drug product. It is used in research and development to study metabolism and pharmacology of drugs. 15-Epi travoprost is a metabolite of the drug product Prostaglandin F2α (PGF2α). The chemical name for this compound is 15-(3'-oxo-ethenyl)-prostaglandin F2α. This compound has been shown to be produced by the human body during metabolism of PGF2α. The CAS number for this compound is 1420791-14-5.

Dha-paclitaxel is a synthetic, natural, and pharmacopoeia impurity standard. It is used as an analytical reference in HPLC to measure paclitaxel content. Dha-paclitaxel may be present in the drug product as a metabolite of paclitaxel. This impurity can be found in the urine or feces of patients who have received paclitaxel therapy.

Fluticasone propionate is a synthetic corticosteroid that is used in the treatment of asthma. It is an esterified prodrug which requires hydrolysis by esterases in order to become active. Fluticasone propionate has shown clinical efficacy with oral administration and can be administered by inhalation or through the skin. This drug is available as a deuterated form for use in nuclear magnetic resonance spectroscopy and reaction monitoring. It also has a linear range of 10-1000 ng/mL and a quadrupole mass spectrometer detection limit of 0.1 pmol, which allows it to be used for plasma samples and reconstituted drugs.

4’-Chloro clomiphene citrate is a drug product that is used as an analytical standard and impurity in the pharmaceutical industry. This compound is a natural metabolite of clomiphene, and is found in urine, serum, liver, and brain tissue. 4’-Chloro clomiphene citrate has been shown to have anti-inflammatory properties.

Please enquire for more information about Loxoprofen methyl-d3 ethyl ester including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about Depyrazine 6,8-dinitrophenyl varenicline including the price, delivery time and more detailed product information at the technical inquiry form on this page

4-(Hydrazinecarbonyl)pyridin-1-ium-1-olate is a medicinal compound that has been shown to have potent anticancer properties. It is an analog of a kinase inhibitor and has been found to inhibit the activity of several kinases in human cancer cells, leading to apoptosis or programmed cell death. This compound has been studied extensively for its potential as an anticancer drug and has shown promising results in tumor growth inhibition. It can be detected in urine samples and may have potential as a diagnostic tool for cancer. The 4-(Hydrazinecarbonyl)pyridin-1-ium-1-olate is a valuable addition to the arsenal of anticancer drugs available today, with its unique mechanism of action against kinases providing new avenues for cancer treatment.

Please enquire for more information about (E)-2-Cyanoethyl 3-aminobut-2-enoate including the price, delivery time and more detailed product information at the technical inquiry form on this page

Olaparib impurity 14 is a metabolite of olaparib. Olaparib is a drug used to treat cancer by inhibiting the activity of PARP1, an enzyme that repairs DNA damage. This impurity is a compound that can be synthesized in high purity and quality with a custom synthesis service. It has been shown to have niche applications in pharmacopoeia, drug development, and analytical studies.

Please enquire for more information about Rosuvastatin EP Impurity C sodium including the price, delivery time and more detailed product information at the technical inquiry form on this page

N-(1-Hydroxy-9H-fluoren-2-yl)-acetamide is an anticancer agent that functions as a kinase inhibitor. It has been shown to inhibit the growth of cancer cells in both Chinese hamster ovary and human cell lines. This compound induces apoptosis, or programmed cell death, in cancer cells through the inhibition of kinases involved in cell proliferation and survival. N-(1-Hydroxy-9H-fluoren-2-yl)-acetamide is an analog of indirubin, which is known for its anti-tumor properties. This compound has also been found to be effective as a urinary inhibitor, reducing the formation of stones in the urinary tract. Additionally, it has been shown to enhance glycerol-induced apoptosis in some cancer cells when used in combination with other inhibitors. Overall, N-(1-Hydroxy-9H-fluoren-2-yl)-acetamide holds great promise as a potential treatment option for various types of

Ulimorelin hydrochloride hydrate is an inhibitor that has been shown to selectively induce apoptosis in cancer cells. This medicinal compound is a protein analog that inhibits the activity of kinases, which are enzymes that play a critical role in tumor growth and progression. Ulimorelin hydrochloride hydrate has been tested on human cancer cell lines and has demonstrated potent anticancer activity. Additionally, it has been found to have inhibitory effects on Chinese hamster ovary (CHO) cells, which suggests potential therapeutic applications beyond cancer treatment. Ulimorelin hydrochloride hydrate is excreted primarily via urine and may be the basis for future research in developing new kinase inhibitors for treating various types of cancer.

2-Bromo-4-chloro-N-methyl-N-phenyl-butanamide is an analog of saxagliptin, a protein inhibitor that has been shown to induce apoptosis in cancer cells. This compound has demonstrated potent anticancer activity in vitro and in vivo, inhibiting the growth of tumor cells by targeting kinases involved in cell proliferation and survival. It has also been found to be effective against a variety of human cancer types, including breast, prostate, and lung cancer. Additionally, 2-Bromo-4-chloro-N-methyl-N-phenyl-butanamide has been shown to have potential as a urine biomarker for detecting early-stage Chinese bladder cancer. Overall, this compound shows promise as a potent inhibitor of cancer cell growth and may have important applications in the development of novel anticancer therapies.

AZD8848 is a potent inhibitor of the protein kinase that has been shown to have anticancer properties. This analog of capsaicin has been tested in Chinese hamster ovary (CHO) and human cancer cell lines, where it was found to induce apoptosis and inhibit tumor growth. AZD8848 targets specific kinases involved in cancer cell proliferation and survival, making it a promising candidate for cancer treatment. In addition to its anticancer effects, AZD8848 has also been shown to have potential as a urine protein inhibitor, which could be useful in the diagnosis and monitoring of certain types of cancer. Overall, AZD8848 represents an exciting new avenue for the development of novel anticancer therapies.

Epinephrine sulfonic acid-d3 is a synthetic, high purity, pharmacopoeia, drug development, analytical standard. It is used as an impurity standard, and in the synthesis of epinephrine sulfone. Epinephrine sulfonic acid-d3 has been shown to be a metabolite of epinephrine and its metabolites. This product has been synthesized and characterized by HPLC analysis using an ion-pairing agent and a gradient elution with water:acetonitrile (0.1% formic acid) (75:25).

Anilopam is an analog that has been identified as a potential anticancer agent. It works by inhibiting protein kinases, which are enzymes that play a crucial role in the growth and proliferation of cancer cells. Anilopam has been shown to inhibit the activity of several tumor-associated kinases, including those involved in cell cycle regulation and apoptosis. This medicinal compound has demonstrated potent antitumor activity in human cancer cell lines and has also shown promising results in preclinical studies. Anilopam is excreted primarily in urine and may have potential as a urinary biomarker for cancer diagnosis or monitoring treatment response. Its ability to inhibit kinase activity makes it a promising therapeutic option for the treatment of various types of cancers.

Roflumilast is a drug used to treat chronic obstructive pulmonary disease. It is also used to treat inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. Roflumilast inhibits the enzyme cytochrome P450 in the liver, which is responsible for metabolizing certain drugs and other substances. This inhibition reduces the metabolism of these substances, leading to increased levels of these substances in the body. This can lead to side effects such as nausea, vomiting, dizziness, headache, and itching. Roflumilast also has an anti-inflammatory effect on the intestines by regulating the production of inflammatory cytokines and inhibiting the activity of pro-inflammatory enzymes.

Mometasone Furoate EP Impurity J is a natural, non-synthetic impurity found in the drug product Mometasone Furoate EP. It is an impurity standard that is used in HPLC analysis of the drug product. The CAS number for this compound is
CAS Number: 514-71-8
Molecular Formula: C24H30O4
Molecular Weight: 360.48
Synonyms: Mometasone Furoate EP Impurity J;5α-pregna-1,4-diene-3,20 dione, 16-[(6-chloro-3-pyridinyl)oxy]-11β,17α,21-(epoxy)-
Impurity Standard for Mometasone Furoate EP

Gemcitabine hydrochloride is an analog of the natural nucleoside cytidine. It is a chemotherapeutic drug that is used in the treatment of pancreatic, lung and breast cancer. Gemcitabine hydrochloride is metabolized to its active form by deamination of cytosine residues in DNA. This conversion is catalyzed by the enzyme cytidine deaminase. Gemcitabine hydrochloride has been shown to be effective against metastatic pancreatic cancer and advanced-stage non-small cell lung cancer, as well as early-stage breast cancer. Gemcitabine hydrochloride has also been shown to be effective against certain types of lymphoma and leukemia.